Genetic Testing Progresses, But Cardiologists Still Rely Upon Traditional Diagnostic Techniques, Says American Heart Association

October 05, 1998

DALLAS, October 6 -- While experts agree that genetic testing has helped identify people who may not appear to be at high risk for genetic forms of heart disease, testing most frequently serves to confirm traditional diagnostic methods, according to a new American Heart Association scientific statement. In most instances, cardiologists still depend on traditional means of diagnosis, including non-invasive testing, say the authors in their statement published in today's Circulation: Journal of the American Heart Association.

However, the public is becoming more interested in the link between genes and diseases, says the statement's co-author James Moller, M.D., a Paul Dwan Professor of pediatric cardiology at the University of Minnesota, Minneapolis and Fairview-University Medical Center.

"We see and hear a lot about genetic findings in the news, and people are asking their physicians questions," says Moller, a past president of the AHA. "This report explores the accuracy and usefulness of DNA testing on three major inherited heart-related disorders: hypertrophic cardiomyopathy (HCM), long QT-Syndrome (LQTS), and Marfan Syndrome (MFS)."

The panel, which prepared the statement, also considered societal issues such as employment and insurance discrimination and privacy concerns. According to Moller, the panel's major findings were two-fold. "Some of these diseases have clear-cut clinical features, and you do not need genetic tests to define them," he says. "In others, such as LQTS, the genetic background has not been worked out. Although gene tests can be helpful, a lot of these genes have not been completely defined. We still need to work out more fundamental knowledge."

HCM is a heart defect found in about 1 in 500 persons. It can appear at any stage in life. However, premature death often occurs suddenly. The disease is characterized by increased thickness of the wall of the left ventricle, the largest of the four chambers of the heart.

LQTS is less common and genetically predisposes individuals to fainting spells and sudden cardiac death, typically due to irregular heartbeats brought on by stress or vigorous activity. LQTS is often symptomless and undiagnosed but is acknowledged as a cause of sudden cardiac death in young, apparently healthy people -- notably competitive athletes.

The authors say there are several of difficulties in diagnosing LQTS using conventional methods, which lead to uncertain diagnoses in as many as 50 percent of cases. Thus, they say a genetic diagnosis would give the most accurate information, especially for people who physicians classify as "borderline." MFS is a disease of the connective tissues affecting about 40,000 Americans. People with this defect have a 50-50 chance of passing the condition on to their children. Because the disease principally affects the eyes and bones as well as the cardiovascular system, physicians use physical appearance and clinical tests as the primary means of diagnosis. Not all MFS patients show classic features of the disease and many of these abnormalities appear in the general population, which complicates clinical diagnosis. While diagnostic criteria for MFS are well established, there are many gene mutations associated with the disorder. Therefore, routine molecular screening cannot be used by itself. Genetic testing for MFS can only be regarded as a confirmation of a doctor's office diagnosis, the statement concludes.

"The question the panel was asking was, 'To what extent has laboratory genetic testing changed the landscape of cardiovascular diagnosis?'," says the statement's lead author, Barry Maron, M.D., panel chairman and director of cardiovascular research at the Minnesota Heart Institute Foundation, Minneapolis. "The answer we found was that it hasn't changed things completely and we do still rely on traditional testing. But genetic testing's role has been very important in identifying certain subgroups."

The authors say that access to genetic diagnosis is limited and commercial or governmental involvement will be necessary for widespread DNA diagnosis of cardiovascular diseases. "This statement puts matters into perspective with regard to clinical and molecular diagnoses at this time, and argues that the importance of a doctor's office diagnosis has not been diminished," says Maron. "While molecular diagnosis is not yet widely available, the research tool of DNA diagnosis has already taught us a great deal."

The statement's co-authors are Christine E. Seidman, M.D.; G. Michael Vincent, M.D.; Harry C. Dietz, M.D.; Arthur J. Moss, M.D.; Jeffrey A. Towbin, M.D.; Henry M. Sondheimer, M.D.; Reed E. Pyeritz, M.D., Ph.D.; Glenn McGee, Ph.D.; and Andrew E. Epstein, M.D. All are from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.



American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.